StrokeCog-BBB to Study Cognitive Outcomes Following Stroke

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

The goal of this observational study is to learn about cognitive outcomes in stroke patients. The main question it aims to answer are: 1. Is blood-brain barrier permeability compromised for years after stroke, 2. Is a blood biomarker of imbalanced angiogenesis dysregulated in chronic stroke and 3. Are there biomarkers that separately or together predicts cognitive decline after stroke, and are other MRI, blood, and clinical characteristics that are associated. Participants will undergo cognitive testing and MRIs two years apart. Researchers will compare cognitive outcomes in non-stroke patients who have cardiovascular risk factors to understand the effects of stroke on these outcomes.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 45
Maximum Age: 90
Healthy Volunteers: f
View:

• Aged 45 years or over

• One or more vascular risk factors (e.g. high blood pressure, diabetes or vascular disease such as angina, a previous heart attack, a heart bypass or peripheral artery disease in the legs)

• Established vascular disease (previous MI, angina, vascular stent in the peripheral bed)

• Sufficiently fluent in written and spoken English

• Living independently in the community

• Willing/able to give consent to study participation.

Locations
United States
California
Stanford University Hospital
RECRUITING
Palo Alto
Contact Information
Primary
Muhith Musabbir
musabbir@stanford.edu
650-723-8886
Time Frame
Start Date: 2022-05-17
Estimated Completion Date: 2027-12-31
Participants
Target number of participants: 350
Treatments
Stroke
Patients who have a history of stroke will be in the first group.
Control
Patients who do not have a history of stroke, but have a history of cardiovascular risk factors will be in the second group.
Related Therapeutic Areas
Sponsors
Collaborators: Columbia University, University of Manchester
Leads: Stanford University

This content was sourced from clinicaltrials.gov